Skip to main content
Log in

The neuron-specific enolase-bone morphogenic protein 4 transgenic mouse

A fibrodysplasia ossificans progressiva-like animal model

  • Fibrodysplasia Ossificans Progressiva
  • Published:
Clinical Reviews in Bone and Mineral Metabolism Aims and scope Submit manuscript

Abstract

Fibrodysplasia ossificans progressiva (FOP) is a rare genetic disorder characterized by congenital malformation of the great toes and by progressive, postnatal beterotopic bone formation. Although the genetic defect in FOP is not known, several lines of evidence suggest that dysregulation of bone morphogenetic protein (BMP) 4 may be involved in the pathophysiology of the condition. Transgenic mice that overex press BMP4 under the control of the neuron-specific enolase (Nse) promoter is the first mouse model to develop progressive, postnatal heterotopic endochondral ossification. The Nse-BMP4 transgenic mouse provides a unique opportunity to study the pathophysiology and treatment of progressive heterotopic ossification in an animal model relevant to the study of FOP.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kaplan FS, Shore EM, Connor JM. 2002 Fibrodysplasia ossificans progressiva (FOP). In: Royce PM, Steinmann B, eds. Connective Tissue and Its Heritable Disorders: Molecular, Genetic, and Medical Aspects 2nd Ed. Wiley-Liss: John Wiley & Sons, New York, pp. 827–840.

    Google Scholar 

  2. Shafritz AB, Shore EM, Gannon FH, et al. 1996 Overexpression of an osteogenic morphogen in fibrodysplasia ossificans progressiva. N Engl J Med 335:555–561.

    Article  PubMed  CAS  Google Scholar 

  3. Ahn J, Serrano de la Peña L, Shore EM, Kaplan FS. 2003 Paresis of a bone morphogenetic protein-antagonist response in a genetic disorder of heterotopic skeletogenesis. J Bone Joint Surg Am 85-A(4):667–674.

    PubMed  Google Scholar 

  4. Guha U, Gomes WA, Kobayashi T, Pestell RG, Kessler JA. 2002 In vivo evidence that BMP signaling is necessary for apoptosis in the mouse limb. Dev Biol 249:108–120.

    Article  PubMed  CAS  Google Scholar 

  5. Blessing M, Nanney LB, King LE, Jones CM, Hogan BL. 1993 Transgenic mice as a model to study the role of TGF-beta related molecules in hairfollicles. Genes Dev 7:204–215.

    PubMed  CAS  Google Scholar 

  6. Bellusci S, Henderson R, Winnier G, Oikawa T, Hogan BL. 1996 Evidence from normal expression and targeted misexpression that bone morphogenetic protein (BMP4) plays a role in mouse embryonic lung morphogenesis. Development 122:1693–1702.

    PubMed  CAS  Google Scholar 

  7. Tsumaki N, Nakase T, Miyaji T, et al. 2002 Bone morphogenetic protein signals are required for cartilage formation and differently regulate joint development during skeletogenesis. J Bone Miner Res 17:898–906.

    Article  PubMed  CAS  Google Scholar 

  8. Kan L, Hu M, Gomes WA, Kessler JA. 2004 Transgenic mice overexpressing BMP4 develop a fibrodysplasia ossificans progressiva (FOP)-like phenotype. Am J Pathol 165:1107–1115.

    PubMed  CAS  Google Scholar 

  9. Gomes WA, Mehler MF, Kessler JA. 2003 Transgenic overexpression of BMP4 increases astroglial and decreases oligodendroglial lineage commitment. Dev Biol 255:164–177.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lixin Kan PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kan, L. The neuron-specific enolase-bone morphogenic protein 4 transgenic mouse. Clinic Rev Bone Miner Metab 3, 235–237 (2005). https://doi.org/10.1385/BMM:3:3-4:235

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1385/BMM:3:3-4:235

Key Words

Navigation